For research & informational purposes only.  Nothing on this site is medical advice or a recommendation to use any compound.

BPC-157 & TB-500

Tissue-repair research peptides · often studied and used together
Status: Research only · not approved Evidence: Largely animal Sport: WADA-prohibited Prescription: Not available

What they are

BPC-157 ("Body Protection Compound") is a 15-amino-acid peptide fragment originally derived from a protein found in human gastric juice. TB-500 is a synthetic version of a region of thymosin beta-4, a naturally occurring protein involved in cell movement and tissue repair. They are frequently paired in recovery research because their proposed mechanisms are complementary.

Not approved — and prohibited in sport Neither BPC-157 nor TB-500 is approved for human use by any regulator. BPC-157 is on the World Anti-Doping Agency prohibited list (class S0, non-approved substances). Products are typically sold labelled "research use only" or "not for human consumption."

How they are thought to work

BPC-157 is studied for effects on blood-vessel formation (angiogenesis), nitric-oxide signalling, and growth-factor pathways involved in healing. TB-500 influences actin, a protein essential to cell structure and migration, which is relevant to how cells move into a wound to repair it. In theory, one supports the blood supply and signalling for repair while the other supports cell migration.

What the evidence shows

This is the crucial point: the evidence base is overwhelmingly preclinical. Promising results exist in cell cultures and animal models for tendon, ligament, gut and wound healing, but large randomised human trials are lacking.

  • Animal studies show effects on tissue repair, anti-inflammatory action and gut protection.
  • Much of the BPC-157 literature traces back to a small number of research groups.
  • Human safety data is limited, and long-term human studies essentially do not exist.
  • For TB-500 specifically, the data is mostly animal-based with very little human data.
Human evidence
Minimal
Animal evidence
Promising
Regulatory standing
None
Long-term safety data
Absent

Safety questions that remain open

Because BPC-157 promotes blood-vessel formation, there is a theoretical concern that it could also support the growth of undetected pre-cancerous cells. There is currently no long-term human data to confirm or rule out this risk, which is precisely why regulators urge caution. Product quality is a further issue: research-grade material has no oversight on purity, dose accuracy or contamination.

Reading the popularity honestly These peptides are popular in recovery and biohacking circles, and many users report benefits anecdotally. Anecdote is not evidence. The gap between strong online enthusiasm and weak human data is large, and worth keeping front of mind.

Where they stand

Interesting compounds with real preclinical signals, but unproven and unregulated in humans. They are not legal to sell as medicines or supplements for human use in most jurisdictions, they are banned in tested sport, and their safety profile in people is genuinely unknown.

Research & informational purposes only This page summarises published research. It is not a recommendation to obtain or use BPC-157 or TB-500.

References

  1. Multifunctionality and Possible Medical Application of the BPC 157 Peptide (review), 2025. PMC
  2. BPC-157: A prohibited peptide and an unapproved drug. Operation Supplement Safety (US DoD). OPSS
  3. BPC-157 Prohibited. US Anti-Doping Agency. USADA
  4. BPC-157 and TB-500: Background, Indications, Efficacy and Safety, 2025. GlobalRPH